Adding exogenous aGM1 effectively equalized surface aGM1 in both normal and CF cell lines as measured by antibodies to aGM1 or PNA lectin binding, and actually increased GFP-PAO1 binding to the non CF relative to the CF cell line. Here, SMOX is linked to cystic fibrosis.